Semmax Financial Advisors Inc. Acurx Pharmaceuticals, Inc. Transaction History
Semmax Financial Advisors Inc.
- $355 Million
- Q3 2024
A detailed history of Semmax Financial Advisors Inc. transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Semmax Financial Advisors Inc. holds 5,879 shares of ACXP stock, worth $4,938. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,879
Previous 5,879
-0.0%
Holding current value
$4,938
Previous $13,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ACXP
# of Institutions
26Shares Held
1.25MCall Options Held
9.3KPut Options Held
9.7K-
Vanguard Group Inc Valley Forge, PA529KShares$444,6530.0% of portfolio
-
Prospect Financial Services LLC Melville, NY295KShares$247,8630.35% of portfolio
-
Geode Capital Management, LLC Boston, MA147KShares$123,0600.0% of portfolio
-
Morgan Stanley New York, NY46.2KShares$38,8080.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC44.8KShares$37,6150.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $9.71M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...